1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa (EDCTP3-2024-01-03) is sponsored by Global Health EDCTP3 Joint Undertaking (European Commission). This grant supports accelerating the development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa, as detailed in the Global Health EDCTP3 2024 Work Programme.
It is a two-stage call.
Get alerted about grants like this
Save a search for “Global Health EDCTP3 Joint Undertaking (European Commission)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Researchers worldwide can participate, as long as they collaborate with European and sub-Saharan African partners. Confirm the full requirements in the official notice before applying.
Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa (EDCTP3-2024-01-03) is funded by Global Health EDCTP3 Joint Undertaking (European Commission). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Developing novel, innovative HIV therapeutics for reducing the disease burden of HIV in sub-Saharan Africa (EDCTP3-2024-01-01) is sponsored by Global Health EDCTP3 Joint Undertaking (European Commission). This call is part of the Global Health EDCTP3 2024 Work Programme and focuses on developing novel and innovative HIV therapeutics to reduce the burden of HIV in sub-Saharan Africa. It is a two-stage call.
Research on existing Malaria vaccines and development of new promising candidates (EDCTP3-2024-01-02) is sponsored by Global Health EDCTP3 Joint Undertaking (European Commission). This call aims to support research on existing malaria vaccines and the development of new promising candidates, as outlined in the Global Health EDCTP3 2024 Work Programme. It is a two-stage call.
New tools, technologies and approaches for vector control in sub-Saharan Africa (EDCTP3-2024-01-05) is sponsored by Global Health EDCTP3 Joint Undertaking (European Commission). Part of the Global Health EDCTP3 2024 Work Programme, this call supports the development of new tools, technologies, and approaches for vector control in sub-Saharan Africa. It is a two-stage call.
The Eli Lilly and Company Foundation's 2026 Open Call opened June 1 and closes July 3, across three focus areas: Global Health, K-12 STEM Education, and Economic Mobility. But two of the three only fund Marion County, Indiana. Here is how to read the geographic fine print, why the funder's commercial identity shapes what wins, and how to position a proposal that actually fits.
Read articleThe Lilly Foundation's 2026 Open Call accepts pre-applications June 1 through July 3. Its three priorities — Global Health, K-12 STEM Education, and Economic Mobility — look national, but the education and mobility tracks concentrate heavily in Marion County, Indiana, while the health track funds cardiometabolic work abroad. Here's how to read the geography before you spend a week on a pre-application you can't win.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read article